Prostamide receptor antagonists

Details Prostamide receptor antagonists Prostamide receptor antagonists

2006-05-16

2006-05-16

Saeed, Kamal A. (Department: 1626)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

active

07045634

ABSTRACT:
The present invention provides prostamide receptor antagonist compounds that may be represented by the general formula I.wherein A, R1, R2, R3, R4and R6are as defined in the specification.

REFERENCES:
patent: 4632928 (1986-12-01), Rettegi et al.
patent: 5100889 (1992-03-01), Misra et al.
patent: 5153327 (1992-10-01), Misra et al.
patent: 5605917 (1997-02-01), Ogletree
patent: 5747660 (1998-05-01), Orlicky
patent: 5955575 (1999-09-01), Peri et al.
patent: 6369089 (2002-04-01), Burk et al.
patent: 6395787 (2002-05-01), Woodward et al.
patent: 6407250 (2002-06-01), Burk et al.
patent: 6509364 (2003-01-01), Burk et al.
patent: 6511999 (2003-01-01), Burk et al.
patent: 2002/0094974 (2002-07-01), Castelhano et al.
patent: 2002/0165399 (2002-11-01), Burk et al.
patent: 0391652 (1990-02-01), None
patent: 0391652 (1990-10-01), None
patent: 391652 (1990-10-01), None
patent: 0448274 (1991-09-01), None
patent: WO 02/22620 (2002-03-01), None
Albuquerque, et al. “Four-Dimensional Quantitative Structure-Activity Relationship Analysis of a Series of Interphenylene 7-Oxabicycloheptane Oxazole Thromboxane A2 Receptor Antagonists,” J. Chem. Inf. Comput. Sci., vol. 38, pp. 925-938 (1998).
Misra, et al. “Interphenylene 7-Oxabicyclo[2.2.1]heptane Oxazoles. Highly Potent, Selective, and Long-Acting Thromboxane A2 Receptor Antagonists,” J. Med.Chem. vol. 36, pp. 1401-1417 (1993).
Misra et al., “Interphenylene 7-oxabicyclo[2.2.1]heptane oxazoles. Highly potent, selective, and long-acting thromboxane A2 receptor antagonists,” J. Med. Chem., vol. 36, No. 10, pp. 1401-1417 (1993).
Liang et al, “Composition of Prostaglandin F2a, Bimatoprost (Prostamide), and Butaprost (EP2 Agonist) on Cyr61 and Connective Tissue Growth Factor Gene Expression”, Journal of Biological Chemistry, vol. 278, No. 29, Jul. 18, 2003, pp. 27267-27277.
Koda et al, “Synthesis of prostaglandin F ethanolamide by prostaglandin F synthase and identification of Bimatoprost as a potent inhibitor of the enzyme: new enzyme assay method using LC/ESI/MS”, Archives of Biochemistry and Biophysics, vol. 424, No. 2, Apr. 15, 2004, pp. 128-136.
Gandolfi et al, “Effect of Bimatoprost on Patients with Primary Open-angle Glaucoma or Ocular Hypertension Who are Nonresponders to Latanoprost”, Ophthalmology, vol. 110, No. 3, Mar. 2003, 609-614.
Misra et al, “Interphenylene 7-Oxabicyclo [2.2.1]heptane Oxazoles. Highly Potent, Selective, and Long-Acting Thromboxane A2Receptor Antagonists”, J. Med. Chem., 1993, 36, 1401-1417.

Affiliated with

Also associated with

Rating

Prostamide receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Prostamide receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prostamide receptor antagonists will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3647602